The distinct clinical profile of chronically critically ill patients: a cohort study

被引:42
作者
Estenssoro, Elisa [1 ]
Reina, Rosa
Canales, Hector S.
Gabriela Saenz, Maria
Gonzalez, Francisco E.
Aprea, Maria M.
Laffaire, Enrique
Gola, Victor
Dubin, Arnaldo
机构
[1] Hosp Interzonal Gen San Martin, Serv Terapia Intens, Buenos Aires, DF, Argentina
[2] Sanat Otamendi y Miroli, Crit Care Unit, Buenos Aires, DF, Argentina
关键词
D O I
10.1186/cc4941
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction Our goal was to describe the epidemiology, clinical profiles, outcomes, and factors that might predict progression of critically ill patients to chronically critically ill (CCI) patients, a still poorly characterized subgroup. Methods We prospectively studied all patients admitted to a university-affiliated hospital intensive care unit (ICU) between 1 July 2002 and 30 June 2005. On admission, we recorded epidemiological data, the presence of organ failure (multiorgan dysfunction syndrome (MODS)), underlying diseases (McCabe score), acute respiratory distress syndrome ( ARDS) and shock. Daily, we recorded MODS, ARDS, shock, mechanical ventilation use, lengths of ICU and hospital stay (LOS), and outcome. CCI patients were defined as those having a tracheotomy placed for continued ventilation. Clinical complications and time to tracheal decannulation were registered. Predictors of progression to CCI were identified by logistic regression. Results Ninety-five patients (12%) fulfilled the CCI definition and, compared with the remaining 690 patients, these CCI patients were sicker (APACHE II, 21 +/- 7 versus 18 +/- 9 for non-CCI patients, p = 0.005); had more organ dysfunctions ( SOFA 7 +/- 3 versus 6 +/- 4, p < 0.003); received more interventions TISS 32 +/- 10 versus 26 +/- 8, p < 0.0001); and had less underlying diseases and had undergone emergency surgery more frequently ( 43 versus 24%, p = 0.001). ARDS and shock were present in 84% and 83% of CCI patients, respectively, versus 44% and 48% in the other patients ( p < 0.0001 for both). CCI patients had higher expected mortality (38% versus 32%, p = 0.003), but observed mortality was similar ( 32% versus 35%, p = 0.59). Independent predictors of progression to CCI were ARDS on admission, APACHE II and McCabe scores ( odds ratio ( OR) 2.26, p < 0.001; OR 1.03, p < 0.01; and OR 0.34, p < 0.0001, respectively). Lengths of mechanical ventilation, ICU and hospital stay were 33 ( 24 to 50), 39 ( 29 to 55) and 55 ( 37 to 84) days, respectively. Tracheal decannulation was achieved at 40 +/- 19 days. Conclusion CCI patients were a severely ill population, in which ARDS, shock, and MODS were frequent on admission, and who suffered recurrent complications during their stay. However, their prognosis was equivalent to that of the other ICU patients. ARDS, APACHE II and McCabe scores were independent predictors of evolution to chronicity.
引用
收藏
页数:9
相关论文
共 46 条
  • [1] *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
  • [3] Characteristics and outcomes of patients who self-extubate from ventilatory support - A case-control study
    Atkins, PM
    Mion, LC
    Mendelson, W
    Palmer, RM
    Slomka, J
    Franko, T
    [J]. CHEST, 1997, 112 (05) : 1317 - 1323
  • [4] THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION
    BERNARD, GR
    ARTIGAS, A
    BRIGHAM, KL
    CARLET, J
    FALKE, K
    HUDSON, L
    LAMY, M
    LEGALL, JR
    MORRIS, A
    SPRAGG, R
    COCHIN, B
    LANKEN, PN
    LEEPER, KV
    MARINI, J
    MURRAY, JF
    OPPENHEIMER, L
    PESENTI, A
    REID, L
    RINALDO, J
    VILLAR, J
    VANASBECK, BS
    DHAINAUT, JF
    MANCEBO, J
    MATTHAY, M
    MEYRICK, B
    PAYEN, D
    PERRET, C
    FOWLER, AA
    SCHALLER, MD
    HUDSON, LD
    HYERS, T
    KNAUS, W
    MATTHAY, R
    PINSKY, M
    BONE, RC
    BOSKEN, C
    JOHANSON, WG
    LEWANDOWSKI, K
    REPINE, J
    RODRIGUEZROISIN, R
    ROUSSOS, C
    ANTONELLI, MA
    BELOUCIF, S
    BIHARI, D
    BURCHARDI, H
    LEMAIRE, F
    MONTRAVERS, P
    PETTY, TL
    ROBOTHAM, J
    ZAPOL, W
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) : 818 - 824
  • [5] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [6] Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations
    Bolton, CF
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (08) : 1408 - 1416
  • [7] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [8] Challenges in end-of-life care in the ICU - Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003
    Carlet, J
    Thijs, LG
    Antonelli, M
    Cassell, J
    Cox, P
    Hill, N
    Hinds, C
    Pimentel, JM
    Reinhart, K
    Thompson, BT
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (05) : 770 - 784
  • [9] Outcomes after long-term acute care - An analysis of 133 mechanically ventilated patients
    Carson, SS
    Bach, PB
    Brzozowski, L
    Leff, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (05) : 1568 - 1573
  • [10] The epidemiology and costs of chronic critical illness
    Carson, SS
    Bach, PB
    [J]. CRITICAL CARE CLINICS, 2002, 18 (03) : 461 - +